483 related articles for article (PubMed ID: 19121649)
1. A retrospective single-center review of primary sclerosing cholangitis in children.
Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
[TBL] [Abstract][Full Text] [Related]
2. Primary sclerosing cholangitis in children: a long-term follow-up study.
Feldstein AE; Perrault J; El-Youssif M; Lindor KD; Freese DK; Angulo P
Hepatology; 2003 Jul; 38(1):210-7. PubMed ID: 12830004
[TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis.
Zein CO; Lindor KD
Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for liver biopsy in primary sclerosing cholangitis?
Burak KW; Angulo P; Lindor KD
Am J Gastroenterol; 2003 May; 98(5):1155-8. PubMed ID: 12809842
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
6. [Primary sclerosing cholangitis--diagnosis and therapy].
Virović L; Supanc V; Duvnjak M
Acta Med Croatica; 2003; 57(3):207-19. PubMed ID: 14582467
[TBL] [Abstract][Full Text] [Related]
7. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
8. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis.
Rodriguez HJ; Bass NM
Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
[TBL] [Abstract][Full Text] [Related]
10. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.
Boberg KM; Fausa O; Haaland T; Holter E; Mellbye OJ; Spurkland A; Schrumpf E
Hepatology; 1996 Jun; 23(6):1369-76. PubMed ID: 8675153
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
van Milligen de Wit AW; van Deventer SJ; Tytgat GN
Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases.
McNair AN; Moloney M; Portmann BC; Williams R; McFarlane IG
Am J Gastroenterol; 1998 May; 93(5):777-84. PubMed ID: 9625127
[TBL] [Abstract][Full Text] [Related]
13. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR
Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P
Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
[TBL] [Abstract][Full Text] [Related]
16. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome.
Abdo AA; Bain VG; Kichian K; Lee SS
Hepatology; 2002 Dec; 36(6):1393-9. PubMed ID: 12447864
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
Okolicsanyi L; Fabris L; Viaggi S; Carulli N; Podda M; Ricci G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
[TBL] [Abstract][Full Text] [Related]
18. Small-duct primary sclerosing cholangitis: a long-term follow-up study.
Angulo P; Maor-Kendler Y; Lindor KD
Hepatology; 2002 Jun; 35(6):1494-500. PubMed ID: 12029635
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis.
Schimanski U; Stiehl A; Stremmel W; Theilmann L
Endoscopy; 1996 May; 28(4):346-9. PubMed ID: 8813500
[TBL] [Abstract][Full Text] [Related]
20. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
Nakazawa T; Ohara H; Sano H; Ando T; Aoki S; Kobayashi S; Okamoto T; Nomura T; Joh T; Itoh M
Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
